NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.789
-0.054 (-6.43%)
At close: Mar 9, 2026, 4:00 PM EDT
0.788
-0.001 (-0.06%)
After-hours: Mar 9, 2026, 5:49 PM EDT

NMTC Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2020 - 2016
Net Income
-6.83-3.61-12.32-11.86-10-9.95
Upgrade
Depreciation & Amortization
0.260.260.250.20.120.08
Upgrade
Other Amortization
-0.32----0
Upgrade
Loss (Gain) From Sale of Assets
---0.03--
Upgrade
Loss (Gain) From Sale of Investments
----0.05-0.01-
Upgrade
Stock-Based Compensation
1.281.261.341.110.951.79
Upgrade
Other Operating Activities
-0.16-0.330.670.110.21-0.02
Upgrade
Change in Accounts Receivable
-0.29-1.09-0.180.030.02-0.05
Upgrade
Change in Inventory
0.250.4-0.91-1.02-0.61-0.1
Upgrade
Change in Accounts Payable
-0.190.240.07-0.250.52-0.35
Upgrade
Change in Other Net Operating Assets
-0.170.020.06-1.191.29-0.02
Upgrade
Operating Cash Flow
-6.16-2.84-11.01-12.89-7.52-8.6
Upgrade
Capital Expenditures
-0.1-0.08-0.12-0.38-0.28-0.07
Upgrade
Sale of Property, Plant & Equipment
---0.01--
Upgrade
Investment in Securities
---3.03-2.97-
Upgrade
Investing Cash Flow
-0.1-0.08-0.122.65-3.24-0.07
Upgrade
Issuance of Common Stock
9.799.615.878.5913.359.11
Upgrade
Repurchase of Common Stock
-0.12-0.12-0.08-0.12--
Upgrade
Other Financing Activities
-0.98-1.461.48-1.07-1.332.42
Upgrade
Financing Cash Flow
8.698.037.277.412.0211.53
Upgrade
Net Cash Flow
2.435.11-3.86-2.841.262.86
Upgrade
Free Cash Flow
-6.26-2.92-11.13-13.27-7.79-8.67
Upgrade
Free Cash Flow Margin
-53.42%-24.13%-322.39%-389.45%-367.67%-3568.48%
Upgrade
Free Cash Flow Per Share
-0.14-0.07-0.42-0.73-0.49-0.81
Upgrade
Levered Free Cash Flow
-3.92-1.78-6.72-8.86-4.18-5.07
Upgrade
Unlevered Free Cash Flow
-3.59-1.65-6.65-8.86-4.18-5.07
Upgrade
Change in Working Capital
-0.39-0.43-0.95-2.431.21-0.51
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.